IHL 0.00% 4.1¢ incannex healthcare limited

phase Phase II data read out end of H2 2024 - should that data...

  1. 4,268 Posts.
    lightbulb Created with Sketch. 8295
    phase
    Phase II data read out end of H2 2024 - should that data packet substantiate and demonstrate improved statistical significance in line with the previous stage 2 study results then there is every possibility this product gets acquired on the strength of that outcome -

    especially with this guy doing the inside work on 42X\
    https://finance.yahoo.com/news/incannex-appoints-fda-regulatory-affairs-120000576.html
    smile.png
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.